Video demonstrating the mechanism of action of a Targeted Alpha Therapeutic (TAT) to treat cancer. Fusion uses medical isotopes and its proprietary Fast-Clear(TM) Linker Technology to make TATs. Fusion's lead asset (FPI-1434) is an investigational drug, currently undergoing clinical testing for various tumor types. Anti-tumor mechanism and efficacy have been demonstrated in non-clinical experiments only.
Posted with permission from Fusion Pharmaceuticals Inc
Keywords: Animation, 3D, Video, Advertising / Marketing, Multimedia, Anatomy, Biotechnology, Molecular Biology, Health & Wellness